Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Other Working Capital Changes (2020 - 2025)

Oncology Institute (TOI) has disclosed Other Working Capital Changes for 6 consecutive years, with $25000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Working Capital Changes fell 96.94% year-over-year to $25000.0, compared with a TTM value of -$3.6 million through Sep 2025, down 71.45%, and an annual FY2024 reading of -$2.8 million, up 9.59% over the prior year.
  • Other Working Capital Changes was $25000.0 for Q3 2025 at Oncology Institute, up from -$1.2 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $9.1 million in Q4 2021 and bottomed at -$3.5 million in Q4 2024.
  • Average Other Working Capital Changes over 5 years is -$44764.7, with a median of -$256000.0 recorded in 2022.
  • The sharpest move saw Other Working Capital Changes plummeted 7378.12% in 2022, then soared 710.53% in 2024.
  • Year by year, Other Working Capital Changes stood at $9.1 million in 2021, then crashed by 102.81% to -$256000.0 in 2022, then plummeted by 967.97% to -$2.7 million in 2023, then decreased by 27.21% to -$3.5 million in 2024, then skyrocketed by 100.72% to $25000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for TOI at $25000.0 in Q3 2025, -$1.2 million in Q2 2025, and $1.1 million in Q1 2025.